mRNA-Therapie: Stand der Forschung, Chancen & Risiken
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | German |
| Veröffentlicht: |
Norderstedt
BoD – Books on Demand
2021
|
| Ausgabe: | 2. Auflage |
| Schlagworte: | |
| Online-Zugang: | Inhaltstext |
| Beschreibung: | 191 Seiten 21 cm x 14.8 cm, 286 g |
| ISBN: | 9783754329498 3754329499 |
Internformat
MARC
| LEADER | 00000nam a22000008c 4500 | ||
|---|---|---|---|
| 001 | BV047564183 | ||
| 003 | DE-604 | ||
| 005 | 20211112 | ||
| 007 | t | ||
| 008 | 211028s2021 gw |||| 00||| ger d | ||
| 015 | |a 21,N32 |2 dnb | ||
| 016 | 7 | |a 123845643X |2 DE-101 | |
| 020 | |a 9783754329498 |c Paperback : EUR 14.95 (DE), EUR 15.40 (AT), CHF 21.90 (freier Preis) |9 978-3-7543-2949-8 | ||
| 020 | |a 3754329499 |9 3-7543-2949-9 | ||
| 024 | 3 | |a 9783754329498 | |
| 035 | |a (OCoLC)1263353010 | ||
| 035 | |a (DE-599)DNB123845643X | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c XA-DE-SH | ||
| 049 | |a DE-37 | ||
| 084 | |8 1\p |a 610 |2 23sdnb | ||
| 100 | 1 | |a Schmitz-Buchholz, Daniel |d 1976- |e Verfasser |0 (DE-588)124721532 |4 aut | |
| 245 | 1 | 0 | |a mRNA-Therapie |b Stand der Forschung, Chancen & Risiken |c Daniel Schmitz-Buchholz |
| 250 | |a 2. Auflage | ||
| 263 | |a 202108 | ||
| 264 | 1 | |a Norderstedt |b BoD – Books on Demand |c 2021 | |
| 300 | |a 191 Seiten |c 21 cm x 14.8 cm, 286 g | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Messenger-RNS |0 (DE-588)4169499-5 |2 gnd |9 rswk-swf |
| 653 | |a mRNA-Therapie | ||
| 653 | |a Corona Impfung | ||
| 653 | |a mRNA | ||
| 653 | |a mRNA Buch | ||
| 653 | |a Corona Impfstoff | ||
| 689 | 0 | 0 | |a Messenger-RNS |0 (DE-588)4169499-5 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Messenger-RNS |0 (DE-588)4169499-5 |D s |
| 689 | 1 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 710 | 2 | |a Books on Demand GmbH (Norderstedt) |0 (DE-588)10068934-6 |4 pbl | |
| 856 | 4 | 2 | |m X:MVB |q text/html |u http://deposit.dnb.de/cgi-bin/dokserv?id=02fbb0f9b7a148f4be741d16bc42fbd6&prov=M&dok_var=1&dok_ext=htm |3 Inhaltstext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032939570 | ||
| 883 | 1 | |8 1\p |a vlb |d 20210807 |q DE-101 |u https://d-nb.info/provenance/plan#vlb | |
Datensatz im Suchindex
| _version_ | 1804182892468764672 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Schmitz-Buchholz, Daniel 1976- |
| author_GND | (DE-588)124721532 |
| author_facet | Schmitz-Buchholz, Daniel 1976- |
| author_role | aut |
| author_sort | Schmitz-Buchholz, Daniel 1976- |
| author_variant | d s b dsb |
| building | Verbundindex |
| bvnumber | BV047564183 |
| ctrlnum | (OCoLC)1263353010 (DE-599)DNB123845643X |
| edition | 2. Auflage |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01987nam a22005538c 4500</leader><controlfield tag="001">BV047564183</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20211112 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">211028s2021 gw |||| 00||| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,N32</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">123845643X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783754329498</subfield><subfield code="c">Paperback : EUR 14.95 (DE), EUR 15.40 (AT), CHF 21.90 (freier Preis)</subfield><subfield code="9">978-3-7543-2949-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3754329499</subfield><subfield code="9">3-7543-2949-9</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783754329498</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1263353010</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB123845643X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-SH</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-37</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schmitz-Buchholz, Daniel</subfield><subfield code="d">1976-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)124721532</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">mRNA-Therapie</subfield><subfield code="b">Stand der Forschung, Chancen & Risiken</subfield><subfield code="c">Daniel Schmitz-Buchholz</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. Auflage</subfield></datafield><datafield tag="263" ind1=" " ind2=" "><subfield code="a">202108</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Norderstedt</subfield><subfield code="b">BoD – Books on Demand</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">191 Seiten</subfield><subfield code="c">21 cm x 14.8 cm, 286 g</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Messenger-RNS</subfield><subfield code="0">(DE-588)4169499-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mRNA-Therapie</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Corona Impfung</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mRNA Buch</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Corona Impfstoff</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Messenger-RNS</subfield><subfield code="0">(DE-588)4169499-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Messenger-RNS</subfield><subfield code="0">(DE-588)4169499-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Books on Demand GmbH (Norderstedt)</subfield><subfield code="0">(DE-588)10068934-6</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=02fbb0f9b7a148f4be741d16bc42fbd6&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032939570</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">vlb</subfield><subfield code="d">20210807</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#vlb</subfield></datafield></record></collection> |
| id | DE-604.BV047564183 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T18:28:07Z |
| indexdate | 2024-07-10T09:14:46Z |
| institution | BVB |
| institution_GND | (DE-588)10068934-6 |
| isbn | 9783754329498 3754329499 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032939570 |
| oclc_num | 1263353010 |
| open_access_boolean | |
| owner | DE-37 |
| owner_facet | DE-37 |
| physical | 191 Seiten 21 cm x 14.8 cm, 286 g |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | BoD – Books on Demand |
| record_format | marc |
| spelling | Schmitz-Buchholz, Daniel 1976- Verfasser (DE-588)124721532 aut mRNA-Therapie Stand der Forschung, Chancen & Risiken Daniel Schmitz-Buchholz 2. Auflage 202108 Norderstedt BoD – Books on Demand 2021 191 Seiten 21 cm x 14.8 cm, 286 g txt rdacontent n rdamedia nc rdacarrier Impfstoff (DE-588)4026655-2 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Messenger-RNS (DE-588)4169499-5 gnd rswk-swf mRNA-Therapie Corona Impfung mRNA mRNA Buch Corona Impfstoff Messenger-RNS (DE-588)4169499-5 s Therapie (DE-588)4059798-2 s DE-604 Impfstoff (DE-588)4026655-2 s Books on Demand GmbH (Norderstedt) (DE-588)10068934-6 pbl X:MVB text/html http://deposit.dnb.de/cgi-bin/dokserv?id=02fbb0f9b7a148f4be741d16bc42fbd6&prov=M&dok_var=1&dok_ext=htm Inhaltstext 1\p vlb 20210807 DE-101 https://d-nb.info/provenance/plan#vlb |
| spellingShingle | Schmitz-Buchholz, Daniel 1976- mRNA-Therapie Stand der Forschung, Chancen & Risiken Impfstoff (DE-588)4026655-2 gnd Therapie (DE-588)4059798-2 gnd Messenger-RNS (DE-588)4169499-5 gnd |
| subject_GND | (DE-588)4026655-2 (DE-588)4059798-2 (DE-588)4169499-5 |
| title | mRNA-Therapie Stand der Forschung, Chancen & Risiken |
| title_auth | mRNA-Therapie Stand der Forschung, Chancen & Risiken |
| title_exact_search | mRNA-Therapie Stand der Forschung, Chancen & Risiken |
| title_exact_search_txtP | mRNA-Therapie Stand der Forschung, Chancen & Risiken |
| title_full | mRNA-Therapie Stand der Forschung, Chancen & Risiken Daniel Schmitz-Buchholz |
| title_fullStr | mRNA-Therapie Stand der Forschung, Chancen & Risiken Daniel Schmitz-Buchholz |
| title_full_unstemmed | mRNA-Therapie Stand der Forschung, Chancen & Risiken Daniel Schmitz-Buchholz |
| title_short | mRNA-Therapie |
| title_sort | mrna therapie stand der forschung chancen risiken |
| title_sub | Stand der Forschung, Chancen & Risiken |
| topic | Impfstoff (DE-588)4026655-2 gnd Therapie (DE-588)4059798-2 gnd Messenger-RNS (DE-588)4169499-5 gnd |
| topic_facet | Impfstoff Therapie Messenger-RNS |
| url | http://deposit.dnb.de/cgi-bin/dokserv?id=02fbb0f9b7a148f4be741d16bc42fbd6&prov=M&dok_var=1&dok_ext=htm |
| work_keys_str_mv | AT schmitzbuchholzdaniel mrnatherapiestandderforschungchancenrisiken AT booksondemandgmbhnorderstedt mrnatherapiestandderforschungchancenrisiken |